1998
DOI: 10.1007/bf02471894
|View full text |Cite
|
Sign up to set email alerts
|

Determination of ferrocene-a in blood serum by reversed-phase HPLC using an immobile phase of the C8 type

Abstract: Dihydroxyacetylene compounds of ferrocene are suecessfully used for the prophylaxis of malignant tumors [1]. The most pronounced activity was reported for ferrocene-A (l-ferrocenyl-l-phenyl-2-butin-l,4-diol, FA): the joint introduction of this compound with carcinogens into experimental animals prevented development of the malignant process. FA was also reported to produce an antibacterial effect [2]. In order to elucidate mechanisms of the pharmacological action of FA and study the FA pharmacokinetics, it is … Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles